| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 544333000 | Additional hetero ring which is unsaturated | 38 |
| 20080255358 | Derivatives of Imidazo [1,2-A] Pyridine Useful as Medicaments For Treating Gastrointestinal Diseases - Disclosed are imidazopyridine compounds having the formula: | 10-16-2008 |
| 20090023922 | PROCESS FOR PREPARING VORICONAZOLE, NEW POLYMORPHIC FORM OF INTERMEDIATE THEREOF, AND USES THEREOF - The present invention relates to an improved process for preparation of Voriconazole and Voriconazole (1R)-(−)-10-camphorsulfonate. | 01-22-2009 |
| 20090062541 | Process for catalytically preparing aromatic or heteroaromatic nitriles - The present invention relates to a process for preparing optionally substituted aromatic or heteroaromatic nitriles starting from haloaromatics. These are reacted in a copper-catalysed reaction with potassium hexacyanoferrate(II) or potassium hexacyanoferrate(III) in the presence of heteroaromatic amines. | 03-05-2009 |
| 20090088571 | Synthesis of 6,7-Dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides - Disclosed is a multi-step process for preparing a compound of Formula I: | 04-02-2009 |
| 20090118506 | 6,11-BRIDGED BIARYL MACROLIDES - The present invention discloses compounds of formula I, II or, or pharmaceutically acceptable salts, esters, or prodrugs thereof: | 05-07-2009 |
| 20090124804 | Enantioselective process for preparing a substituted alkanoic acid - The present invention is directed to a process for enantioselectively preparing substituted piperidine alkanoic acid integrin antagonist compounds. | 05-14-2009 |
| 20090137805 | N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES - The present invention relates to novel amides and a process for preparing these amides. | 05-28-2009 |
| 20090149651 | PROCESSES AND INTERMEDIATES FOR PRODUCING AMINOBENZIMIDAZOLE UREAS - The present invention relates to processes and intermediates for the preparation of compounds useful as inhibitors of bacterial gyrase and Topoisomerase IV (Topo IV). | 06-11-2009 |
| 20090264655 | PROCESS FOR PREPARING 2,3-DISUBSTITUTED INDOLES - Disclosed are processes for making 2, 3 disubstituted indole compounds such as compounds of general formula I comprised of the steps of
| 10-22-2009 |
| 20090299066 | TRIAZOLONE DERIVATIVES AS MMP INHIBITORS FOR THE TREATMENT OF ASTHMA AND COPD - The invention provides compounds of formula (I): wherein R | 12-03-2009 |
| 20100056784 | PROCESS FOR THE PREPARATION OF VORICONAZOLE - The present invention relates to an improved process for the preparation of Voriconazole. | 03-04-2010 |
| 20100063284 | SOLID FORMS OF 1-ethyl-3-(5-(5-FLUOROPYRIDIN-3-YL)-7-(PYRIMIDIN-2-YL)-1H-BENZO[D]IMIDAZO- L-2-YL)UREA - Solid forms of crystalline1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-2-yl)urea, compositions containing solid forms of crystalline1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-2-yl)urea and methods of using the same are described. | 03-11-2010 |
| 20100105905 | EP2 Agonists - The invention provides EP2 agonists, methods for their preparation, pharmaceutical compositions containing these compounds, and methods of using these compounds and compositions for lowering intraocular pressure and thereby treating glaucoma. | 04-29-2010 |
| 20100137594 | TETRAZOYLOXIME DERIVATIVE AND PLANT DISEASE CONTROL AGENT - According to the present invention, a tetrazoyloxime derivative and a salt thereof, which are excellent in a control effect against plant disease injury, and a plant disease controlling agent containing the same as an active ingredient are provided. The tetrazoyloxime derivative has a structure represented by formula (1) shown below: | 06-03-2010 |
| 20100292473 | PROCESS FOR PREPARING (2R,3S/2S,3R)-2-(2,4-DIFLUOROPHENYL)-3-(5-FLUOROPYRIMIDIN-4-YL)-1-(1H-1,2- ,4-TRIAZOL-1-YL)BUTAN-2-OL - Voriconazole is prepared by a process comprising condensing 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazole-1-yl)ethanone with 4-chloro-6-ethyl-5-fluoropyrimidine, in a ketone, ether, aliphatic hydrocarbon, or aromatic hydrocarbon solvent, to give (2R,3S/2S,3R)-3-(4-chloro-5-fluoropyrimidin-6-yl)-2-(2,4-diflurophenyl)-1-(1H-1,2,4-triazole-1-yl)butan-2-ol. | 11-18-2010 |
| 20110144334 | ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE - An isoxazoline-substituted benzamide compound of formula (1) or a salt thereof: | 06-16-2011 |
| 20120065396 | ISOINDOLINONE DERIVATIVES, PREPARATION METHOD THEREOF AND A PHARMACEUTICAL COMPOSITION COMPRISING SAME - The present invention relates to an amide compound or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a pharmaceutical composition comprising the same. The inventive amide compound facilitates bone formation and inhibits bone loss, and is therefore useful for preventing and treating bone disorders such as osteoporosis, osteodystrophy, bone fracture, periodontal disease, Paget's disease, bone metastasis, and rheumatoid arthritis. | 03-15-2012 |
| 20120142922 | BENZAMIDE DERIVATIVES - Disclosed are benzamide derivatives useful in slowing the expansion of cancer cells. | 06-07-2012 |
| 20120178933 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative - Novel benzoxazole derivatives are provided to reduce driving voltage of light-emitting elements, and to reduce power consumption of light-emitting elements, light-emitting devices, and electronic devices. A benzoxazole derivative represented by the general formula (G1) is provided. Since the benzoxazole derivative represented by the general formula (G1) has an electron-injecting property, the benzoxazole derivative can be suitably used for light-emitting elements, light-emitting devices, and electronic devices. | 07-12-2012 |
| 20120184741 | SOLID FORMS OF GYRASE INHIBITOR (R)-1-ETHYL-3-[5-[2-(1-HYDROXY-METHYL-ETHYL)PYRIMIDIN-5-YL]-7-(TETRAHYDRO- FURAN-2-YL)-1H-BENZIMIDAZOL-2-YL]UREA - The present application is directed to solid forms of compounds of formula (I): | 07-19-2012 |
| 20120184742 | PROCESS OF MAKING GYRASE AND TOPOISOMERASE IV INHIBITORS - The present application is directed to compounds, intermediates and methods for preparing compounds of formula (I) | 07-19-2012 |
| 20120190852 | MEDICAL COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF GLAUCOMA - The present invention is to provide a medical composition for the treatment or prophylaxis of glaucoma which comprises a pyridylaminoacetic acid compound represented by the formula (1): | 07-26-2012 |
| 20120220772 | NOVEL 3-HYDROXY-5-ARYLISOXAZOLE DERIVATIVE | 08-30-2012 |
| 20130046095 | N-(Heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives, preparation and therapeutic use thereof - The invention concerns compounds of general formula (I), wherein n, X | 02-21-2013 |
| 20130184460 | GLYCINE TRANSPORTER INHIBITING SUBSTANCES - The present invention aims to provide novel compounds of formula [I] or pharmaceutically acceptable salts thereof that are based on a glycine uptake inhibiting action and which are useful in the prevention or treatment of such diseases as schizophrenia, Alzheimer's disease, cognitive dysfunction, dementia, anxiety disorders (generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, social anxiety disorder, posttraumatic stress disorder, specific phobia, acute stress disorder, etc.), depression, drug addiction, spasm, tremor, pain, and sleep disorder: | 07-18-2013 |
| 20130261304 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Benzoxazole Derivative - Novel benzoxazole derivatives are provided to reduce driving voltage of light-emitting elements, and to reduce power consumption of light-emitting elements, light-emitting devices, and electronic devices. A benzoxazole derivative represented by the general formula (G1) is provided. Since the benzoxazole derivative represented by the general formula (G1) has an electron-injecting property, the benzoxazole derivative can be suitably used for light-emitting elements, light-emitting devices, and electronic devices. | 10-03-2013 |
| 20130261305 | PROCESS OF MAKING GYRASE AND TOPOISOMERASE INHIBITORS - The present application is directed to compounds, intermediates and methods for preparing compounds of formula (I) | 10-03-2013 |
| 20130317222 | SOLID FORMS OF GYRASE INHIBITOR (R)-1-ETHYL-3-[5-[2-(1-HYDROXY-1-METHYL-ETHYL)PYRIMIDIN-5-YL]-7-(TETRAHYD- ROFURAN-2-YL]-1H-BENZIMIDAZOL-2-YL]UREA - The present application is directed to solid forms of compounds of formula (I): | 11-28-2013 |
| 20130324728 | PROCESS FOR THE PREPARATION OF AN OREXIN RECEPTOR ANTAGONIST - The present invention is directed to processes for preparing a pyridyl piperidine compound which is an antagonist of orexin receptors, and which is useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. | 12-05-2013 |
| 20140005393 | SULFONAMIDE COMPOUNDS HAVING TRPM8 ANTAGONISTIC ACTIVITY | 01-02-2014 |
| 20140051855 | PENTA-SUBSTITUTED TETRAHYDROPYRIMIDINES WITH AGGREGATION-INDUCED EMISSION CHARACTERISTICS AND PREPARATION METHOD AND USE THEREOF - The present invention provides a series of penta-substituted tetrahydropyrimidines with aggregation-induced emission (AIE) characteristics and preparation method and use thereof. The AIE penta-substituted tetrahydropyrimidines have structures shown as formula (I). R | 02-20-2014 |
| 20140066625 | Fused Imidazole Derivatives Useful as IDO Inhibitors - Presently provided are IDO inhibitors and pharmaceutical compositions thereof, useful for modulating an activity of indoleamine 2,3-dioxygenase; treating indoleanine 2,3-dioxygenase (IDO) mediated immunosuppression; treating a medical conditions that benefit from the inhibition of enzymatic activity of indoleamine-2,3-dioxygenase; enhancing the effectiveness of an anti-cancer treatment comprising administering an anti-cancer agent; treating tumor-specific immunosuppression associated with cancer; and treating immunosupression associated with an infectious disease. | 03-06-2014 |
| 20140081025 | HETEROAROMATIC RING DERIVATIVE - The compound represented by formula (IA) | 03-20-2014 |
| 20140107340 | Benzamides - The present invention is directed to benzamide containing compounds which inhibit the P2X7 receptor | 04-17-2014 |
| 20140316136 | NOVEL ORGANIC ELECTROLUMINESCENCE COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING SAME - The present invention relates to novel organic electroluminescence compounds and an organic electroluminescence device comprising the same. The organic electroluminescence compound according to the present invention has an advantage of manufacturing an OLED device having long operating lifespan due to its high luminous efficiency compared with conventional materials, and having reduced power consumption induced by improved power efficiency. | 10-23-2014 |
| 20140350252 | PROCESS FOR THE PREPARATION OF VORICONAZOLE AND INTERMEDIATES THEREOF - The present invention relates to an improved stereoselective process for the preparation of (2R,3S/2S,3R)-3-(4-chloro-5-fluoropyrimidin-6-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol intermediate compound. This intermediate compound is further used to prepare voriconazole—a triazole antifungal agent. | 11-27-2014 |
| 20140357866 | NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME - The present invention relates to a novel organic electroluminescent compound and an organic electroluminescent device containing the same. Using the organic electroluminescent compounds of the present invention, it is possible to manufacture an OLED device with a long operating lifespan and high luminous efficiency. In addition, the compounds can improve the power efficiency of the device to reduce overall power consumption. | 12-04-2014 |
| 20160130278 | GLYCINE TRANSPORTER INHIBITOR - The present invention provides novel compounds of formula [IA] or pharmaceutically acceptable salts thereof: | 05-12-2016 |
